Health
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death – CNA
The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
GENEVA: The World Health Organization (WHO) said on Saturday (Jul 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospit…
Continue Reading